Temsirolimus peak concentration ( Cmax ) , and sirolimus Cmax and area under the concentration-time curve were decreased in patients receiving p450 enzyme-inducing anticonvulsants ( EIACs ) by 73 % , 47 % , and 50 % , respectively , but were still within the therapeutic range of preclinical models .